Literature DB >> 17149983

Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.

Michael F Jobling1, Joni D Mott, Monica T Finnegan, Vladimir Jurukovski, Anna C Erickson, Peter J Walian, Scott E Taylor, Steven Ledbetter, Catherine M Lawrence, Daniel B Rifkin, Mary Helen Barcellos-Hoff.   

Abstract

The three mammalian transforming growth factor beta (TGF-beta) isoforms are each secreted in a latent complex in which TGF-beta homodimers are non-covalently associated with homodimers of their respective pro-peptide called the latency-associated peptide (LAP). Release of TGF-beta from its LAP, called activation, is required for binding of TGF-beta to cellular receptors, making extracellular activation a critical regulatory point for TGF-beta bioavailability. Our previous work demonstrated that latent TGF-beta1 (LTGF-beta1) is efficiently activated by ionizing radiation in vivo and by reactive oxygen species (ROS) generated by Fenton chemistry in vitro. In the current study, we determined the specific ROS and protein target that render LTGF-beta1 redox sensitive. First, we compared LTGF-beta1, LTGF-beta2 and LTGF-beta3 to determine the generality of this mechanism of activation and found that redox-mediated activation is restricted to the LTGF-beta1 isoform. Next, we used scavengers to determine that ROS activation was a function of OH(.) availability, confirming oxidation as the primary mechanism. To identify which partner of the LTGF-beta1 complex was functionally modified, each was exposed to ROS and tested for the ability to form a latent complex. Exposure of TGF-beta1 did not alter its ability to associate with LAP, but exposing LAP-beta1 to ROS prohibited this phenomenon, while treatment of ROS-exposed LAP-beta1 with a mild reducing agent restored its ability to neutralize TGF-beta1 activity. Taken together, these results suggest that ROS-induced oxidation in LAP-beta1 triggers a conformational change that releases TGF-beta1. Using site-specific mutation, we identified a methionine residue at amino acid position 253 unique to LAP-beta1 as critical to ROS-mediated activation. We propose that LTGF-beta1 contains a redox switch centered at methionine 253, which allows LTGF-beta1 to act uniquely as an extracellular sensor of oxidative stress in tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149983     DOI: 10.1667/RR0695.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  112 in total

Review 1.  Biophysical Approaches for Oral Wound Healing: Emphasis on Photobiomodulation.

Authors:  Imran Khan; Praveen Arany
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-12-01       Impact factor: 4.730

2.  Transforming growth factor- 1 C-509T polymorphism, oxidant stress, and early-onset childhood asthma.

Authors:  Muhammad T Salam; W James Gauderman; Rob McConnell; Pi-Chu Lin; Frank D Gilliland
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

Review 3.  What the lung has taught us about latent TGF-beta activation.

Authors:  Poshala Aluwihare; John S Munger
Journal:  Am J Respir Cell Mol Biol       Date:  2008-11       Impact factor: 6.914

Review 4.  Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection.

Authors:  Julie A Reisz; Nidhi Bansal; Jiang Qian; Weiling Zhao; Cristina M Furdui
Journal:  Antioxid Redox Signal       Date:  2014-02-21       Impact factor: 8.401

Review 5.  Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix.

Authors:  John S Munger; Dean Sheppard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

6.  Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa.

Authors:  Bert Callewaert; Chi-Ting Su; Tim Van Damme; Philip Vlummens; Fransiska Malfait; Olivier Vanakker; Bianca Schulz; Meghan Mac Neal; Elaine C Davis; Joseph G H Lee; Aicha Salhi; Sheila Unger; Ketil Heimdal; Salome De Almeida; Uwe Kornak; Harald Gaspar; Jean-Luc Bresson; Katrina Prescott; Maria E Gosendi; Sahar Mansour; Gérald E Piérard; Suneeta Madan-Khetarpal; Frank C Sciurba; Sofie Symoens; Paul J Coucke; Lionel Van Maldergem; Zsolt Urban; Anne De Paepe
Journal:  Hum Mutat       Date:  2012-08-13       Impact factor: 4.878

Review 7.  Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.

Authors:  Shisuo Du; Mary Helen Barcellos-Hoff
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

Review 8.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

9.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

Review 10.  The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation.

Authors:  Sandra Demaria; Karsten A Pilones; Claire Vanpouille-Box; Encouse B Golden; Silvia C Formenti
Journal:  Radiat Res       Date:  2014-06-17       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.